These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 7507038)

  • 1. Fluvoxamine. An updated review of its pharmacology, and therapeutic use in depressive illness.
    Wilde MI; Plosker GL; Benfield P
    Drugs; 1993 Nov; 46(5):895-924. PubMed ID: 7507038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Citalopram. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in depressive illness.
    Milne RJ; Goa KL
    Drugs; 1991 Mar; 41(3):450-77. PubMed ID: 1711447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paroxetine, sertraline, and fluvoxamine: new selective serotonin reuptake inhibitors.
    Grimsley SR; Jann MW
    Clin Pharm; 1992 Nov; 11(11):930-57. PubMed ID: 1464219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Moclobemide. A review of its pharmacological properties and therapeutic use in depressive illness.
    Fitton A; Faulds D; Goa KL
    Drugs; 1992 Apr; 43(4):561-96. PubMed ID: 1377119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluvoxamine maleate in the treatment of depression: a single-center, double-blind, placebo-controlled comparison with imipramine in outpatients.
    Claghorn JL; Earl CQ; Walczak DD; Stoner KA; Wong LF; Kanter D; Houser VP
    J Clin Psychopharmacol; 1996 Apr; 16(2):113-20. PubMed ID: 8690826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tianeptine: a review of its use in depressive disorders.
    Wagstaff AJ; Ormrod D; Spencer CM
    CNS Drugs; 2001; 15(3):231-59. PubMed ID: 11463130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluvoxamine. An updated review of its use in the management of adults with anxiety disorders.
    Figgitt DP; McClellan KJ
    Drugs; 2000 Oct; 60(4):925-54. PubMed ID: 11085201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lofepramine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depressive illness.
    Lancaster SG; Gonzalez JP
    Drugs; 1989 Feb; 37(2):123-40. PubMed ID: 2649353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Milnacipran. A review of its use in depression.
    Spencer CM; Wilde MI
    Drugs; 1998 Sep; 56(3):405-27. PubMed ID: 9777315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dothiepin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depressive illness.
    Lancaster SG; Gonzalez JP
    Drugs; 1989 Jul; 38(1):123-47. PubMed ID: 2670509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paroxetine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in depressive illness.
    Dechant KL; Clissold SP
    Drugs; 1991 Feb; 41(2):225-53. PubMed ID: 1709852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluvoxamine and tricyclic antidepressants (TCAs): how do the TCAs compare as "new" drugs with established fluvoxamine?
    Ashford JJ
    Int Clin Psychopharmacol; 1995 Jan; 9 Suppl 4():27-31. PubMed ID: 7622820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluvoxamine in the treatment of depressive illness. A series of double-blind hospital based comparative studies carried out in the UK.
    Whitehead AM; Ashford JJ
    Br J Clin Pract; 1992; 46(1):21-3. PubMed ID: 1419548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluvoxamine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depressive illness.
    Benfield P; Ward A
    Drugs; 1986 Oct; 32(4):313-34. PubMed ID: 3096686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A review of fluvoxamine and its uses in depression.
    Burton SW
    Int Clin Psychopharmacol; 1991 Dec; 6 Suppl 3():1-17; discussion 17-21. PubMed ID: 1806631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mirtazapine : A Review of its Pharmacology and Therapeutic Potential in the Management of Major Depression.
    Davis R; Wilde MI
    CNS Drugs; 1996 May; 5(5):389-402. PubMed ID: 26071050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluvoxamine: a review of the controlled trials in depression.
    Ware MR
    J Clin Psychiatry; 1997; 58 Suppl 5():15-23. PubMed ID: 9184623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluvoxamine and clomipramine in depressed hospitalised patients: results from a randomised, double-blind study.
    Ottevanger EA
    Encephale; 1995; 21(4):317-21. PubMed ID: 7588171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and tolerability of moclobemide compared with fluvoxamine in depressive disorder (DSM III). A French/Swiss double-blind trial.
    Bougerol T; Uchida C; Gachoud JP; Köhler M; Mikkelsen H
    Psychopharmacology (Berl); 1992; 106 Suppl():S102-8. PubMed ID: 1546121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative efficacy of antidepressants.
    Kasper S; Fuger J; Möller HJ
    Drugs; 1992; 43 Suppl 2():11-22; discussion 22-3. PubMed ID: 1378369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.